Biocon opens first US manufacturing plant in New Jersey
The facility, operated by Biocon’s wholly-owned subsidiary Biocon Generics Inc., produces oral solid dosage medications with an annual capacity of 2 billion tablets Read More | Source: The Hindu Business Line